Doctorglasses Chain Co

Doctorglasses Chain Co EBITDA Growth YoY

The Year-over-Year EBITDA Growth of Doctorglasses Chain Co (300622.SZ) as of Nov 11, 2026 is 38.03 %. In the previous year, Year-over-Year EBITDA Growth was -19.72 % — a change of -292.84% (higher).

EBITDA Growth YoY

38.03 %

YoY

-292.84%

Last updated:

Year-over-Year EBITDA Growth of Doctorglasses Chain Co is 2025 38.03 % . Year-over-Year EBITDA Growth of Doctorglasses Chain Co was 2024 -19.72 % . It decreases by -292.84% higher compared to the previous year.

The Doctorglasses Chain Co EBITDA Growth YoY history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Growth YoY
Date
EBITDA Growth YoY
Jan 1, 2018
13.92 CNY
Jan 1, 2019
24.38 CNY
Jan 1, 2020
4.70 CNY
Jan 1, 2021
9.77 CNY
Jan 1, 2022
-22.24 CNY
Jan 1, 2023
85.81 CNY
Jan 1, 2024
-19.72 CNY
Jan 1, 2025
38.03 CNY
The Doctorglasses Chain Co EBITDA Growth YoY history
YEAREBITDA Growth YoYYoY
38.03 %-292.84%
-19.72 %-122.98%
85.81 %-485.77%
-22.24 %-327.62%
9.77 %+107.90%
4.70 %-80.72%
24.38 %+75.17%
13.92 %-11.55%
15.74 %-41.69%
26.99 %-970.02%
-3.10 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Doctorglasses Chain Co Stock analysis

What does Doctorglasses Chain Co do? Doctorglasses Chain Co., Ltd. generates revenue through its chain of optical retail stores offering frames, lenses, sunglasses, reading glasses, contact lenses, and care solutions, alongside optometry and optics services. The company operates under the brands President optical, Doctor’s Glasses, zele, and Tong, selling products via direct stores, e-commerce, and wholesale channels. Its primary customer segments include individuals seeking eyewear solutions and optometry services, with a focus on retail and online sales channels. The firm’s product portfolio spans prescription and non-prescription eyewear, including specialized options like reading glasses and contact lenses, supported by care solutions for lens maintenance. Brands such as President optical and Doctor’s Glasses target diverse consumer segments, while zele and Tong cater to specific market niches. Sales through direct stores and e-commerce platforms drive the majority of revenue, complemented by wholesale distribution to other retailers. Doctorglasses Chain Co., Ltd. serves both individual consumers and business clients through its retail and wholesale models. The company’s revenue streams are derived from the sale of eyewear products and associated services, with a strong emphasis on brand-specific product lines. Direct store sales and e-commerce represent the most significant distribution channels, ensuring broad market coverage across its operational regions. Doctorglasses Chain Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Doctorglasses Chain Co stock

Year-over-Year EBITDA Growth of Doctorglasses Chain Co is 38.03 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year EBITDA Growth Doctorglasses Chain Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA growth measures the percentage change in EBITDA compared to the prior year. It shows changes in operating cash earnings before capital structure effects.

To evaluate Year-over-Year EBITDA Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBITDA Growth.

Year-over-Year EBITDA Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBITDA Growth's Doctorglasses Chain Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Doctorglasses Chain Co

All Key Metrics — Doctorglasses Chain Co